|View Video Online Duration: 90 min|
Dramatic advances in biomedical research have been accompanied by an equally dramatic deepening of financial relationships between medical faculty and their institutions with industry sponsors and patrons, and this trend will only intensify in coming years. Research universities and their academic medical centers are increasingly exhorted by political leaders to serve as engines of local and regional socio-economic improvement. Yet the public continues to expect that academic research, and especially clinical research, will be free from any taint of financial conflict of interest. In the face of this serious conflict of public expectation, how best can we protect the welfare of human research participants, investigators, and universities, as well as the integrity of science, while continuing vigorously to facilitate the translation of publicly funded biomedical research discoveries into public benefit?